Please login to the form below

Not currently logged in
Email:
Password:

rights

This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.

‘Common Rulebook’ Brexit plans include medicines – but faces backlash

‘Common Rulebook’ Brexit plans include medicines – but faces backlash

The UK government plans for Brexit, now including the ‘common rulebook’idea has been welcomed as a step in the right direction by the pharma and biotech sectors. ... allow a hard Brexit, Remainers now believe the time is right for a 'People's Vote'

Latest news

More from news
Approximately 2 fully matching, plus 1,094 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 413 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    Gelesis adds to company. Biotech Gelesis has bolstered its offering with the addition of Harry Leider (pictured top right), former chief medical officer and group vice president of pharmacy company Walgreens. ... analytics and clinical reporting

  • Weekly comms appointments Weekly comms appointments

    Sarah Winterbottom joins ROAD. Independent healthcare communications specialist ROAD has appointed Sarah Winterbottom (pictured right) as senior director. ... W2O appoints Ujwal Pyati. W2O, a network of analytics-driven, digital marketing communications

  • Novartis changes executive committee Novartis changes executive committee

    Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its

  • Building trust in our industry Building trust in our industry

    in this industry to do the right thing). ... The percentage of people who trust the pharmaceutical industry to do the right thing has fluctuated only slightly in recent years and in 2018 was only 54.

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Hamermesh (pictured right), who joins from Locust Walk Partners where he served as senior vice president, will lead the business operations and corporate development strategies for the company.

More from appointments
Approximately 0 fully matching, plus 236 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 436 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics